论文部分内容阅读
巴曲酶 (东菱精纯克栓酶 )在我国治疗急性脑梗死已多年 ,有关巴曲酶在治疗急性脑梗死中的溶栓、降纤及脑保护等方面的作用已有多篇报道。既往在使用巴曲酶治疗急性脑梗死时多采用首次 10 U,隔日 5 U,总量 2 0 U的给药方法。为了探讨巴曲酶在不同剂量不同疗程时治疗急性脑梗死的
Batroxobin (Dong Ling Jing Keke acrinase) in our country has been treating acute cerebral infarction for many years, the role of batroxobin in the treatment of acute cerebral infarction in thrombolysis, fibrinolysis and brain protection has been reported in many articles. Past use of batroxobin in the treatment of acute cerebral infarction more than the first 10 U, 5 U every other day, a total of 20 U administration. In order to investigate the batroxobin treatment of acute cerebral infarction at different doses of different courses